STOCK TITAN

ImmunoGen Announces Webcasts of Presentations at Upcoming Virtual Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

WALTHAM, Mass.--()--ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the following presentations by Company management at upcoming investor conferences will be webcast:

  • Piper Sandler 32nd Annual Virtual Healthcare Conference
    November 23 at 10:00am ET
  • Evercore ISI Annual HealthCONx Conference
    December 1 at 12:10pm ET

A webcast of each presentation will be accessible through the Investors and Media section of the Company's website, www.immunogen.com. Following the live webcast, a replay will be available at the same location.

ABOUT IMMUNOGEN

ImmunoGen is developing the next generation of antibody-drug conjugates to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to “target a better now.”

Learn more about who we are, what we do, and how we do it at www.immunogen.com.

Contacts

INVESTOR RELATIONS AND MEDIA
ImmunoGen
Courtney O’Konek
781-895-0600
courtney.okonek@immunogen.com

OR

FTI Consulting
Robert Stanislaro
212-850-5657
robert.stanislaro@fticonsulting.com

Immunogen Inc

NASDAQ:IMGN

IMGN Rankings

IMGN Latest News

IMGN Stock Data

8.72B
278.38M
0.32%
86.52%
7.38%
Biotechnology
Healthcare
Link
United States
Waltham